OTCM
EVARF
Market cap2kUSD
Nov 03, Last price
0.00USD
Name
Lombard Medical Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Lombard Medical, Inc. is a medical technology firm specializing in the creation, production, and distribution of endovascular stent-grafts designed for the repair of aortic aneurysms. The company serves a global market, with operations in the United States, United Kingdom, Germany, Japan, and other international regions. Its leading offering, Aorfix, is an endovascular stent-graft specifically engineered to address abdominal aortic aneurysms (AAAs) where the aneurysm's neck exhibits significant angulation, up to 90 degrees. Other solutions include the Altura endovascular stent graft system, tailored for more conventional AAA anatomies. Furthermore, Lombard Medical provides sophisticated delivery mechanisms: the Aorflex system ensures precise deployment of Aorfix within the abdominal aorta, while the IntelliFlex LP system further enhances the accuracy and control during Aorfix placement and deployment. The firm distributes its products through both its proprietary sales force and a network of distributors, primarily targeting state- or government-operated hospitals. Established in 2000, Lombard Medical, Inc. maintains its corporate headquarters in Didcot, United Kingdom.
Key people
Non-Executive Independent Chairman of the Board · since 2013
William Kullback
Chief Financial Officer · since 2014
Peter Phillips
Chief Technology Officer · since 2011
Simon Hubbert
Chief Executive Officer, Director
Director · since 2015
Non-Executive Director · since 2015
Timothy John Haines
Independent Director · since 2011
Simon Neathercoat
Senior Independent Director · since 2007
Craig Rennie
Independent Director · since 2007
John Rush
Independent Director
Legal address
C/O Codan Trust Company (Cayman) Limited
PO Box 2681
Cricket Square
Hutchins Drive
George Town KY1-1111
KY
PO Box 2681
Cricket Square
Hutchins Drive
George Town KY1-1111
KY
Headquarters
4 Trident Park
Didcot, OXF OX11 7HJ
GB
Didcot, OXF OX11 7HJ
GB
Valuation
Title USD in thousands, except ratios and share amounts | FY |
|---|---|
| 2016‑12 | |
| Income | |
Revenues | |
Cost of revenue | |
Unusual Expense (Income) | |
NOPBT | |
NOPBT Margin | |
Operating Taxes | |
Tax Rate | |
NOPAT | |
Net income | |
Dividends | |
Dividend yield | |
Proceeds from repurchase of equity | |
BB yield | |
| Debt | |
Debt current | |
Long-term debt | |
Deferred revenue | |
Other long-term liabilities | |
Net debt | |
| Cash flow | |
Cash from operating activities | |
CAPEX | |
Cash from investing activities | |
Cash from financing activities | |
FCF | |
| Balance | |
Cash | |
Long term investments | |
Excess cash | |
Stockholders' equity | |
Invested Capital | |
ROIC | |
ROCE | |
| EV | |
Common stock shares outstanding | |
Price | |
Market cap | |
EV | |
EBITDA | |
EV/EBITDA | |
Interest | |
Interest/NOPBT | |